PushCART Therapeutics
Rockville, US · Founded 2025 · Delaware corporation
Founders & leadership
SD
Stephen D. WolpeNamed on SEC filing
LM
Louis M. WeinerNamed on SEC filing
SR
Sean ReinekeNamed on SEC filing
AH
Albert HawkNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2026
▶$500KraisedJul 2026 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen D. WolpeExecutive Officer, Director
- Louis M. WeinerDirector
- Sean ReinekeDirector
- Albert HawkDirector
- Offering amount
- $2M
- Amount sold
- $500K
- Minimum investment
- $50K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has PushCART Therapeutics raised?
- PushCART Therapeutics has disclosed $500K raised across 1 round.
- Where is PushCART Therapeutics headquartered?
- PushCART Therapeutics is headquartered in Rockville, US.